. Generation of genome-edited hiPSC lines. A, Using CRISPR/Cas9 technology, the c.242C>T p.S81L GNB5 mutation was inserted into a control hiPSC line in heterozygous and homozygous state. B, Location of the c.242C>T mutation in the GNB5 transcript and the surrounding sequence. The gRNA sequence that was used is indicated in blue, the PAM sequence in bold. In the single-stranded oligonucleotide (ssODN) that was applied for homologous recombination the c.242C>T mutation is indicated in red and bold, whereas red and italic indicates the synonymous mutation 
. Action potential (AP) characteristics of retinoic acid (RA) and DMSO-treated hiPSCCMs. A. Typical example of an action potential when paced at 1 Hz. B. Action potential duration at 20%, 50% and 80% of repolarization (APD20, APD50 and APD80 respectively). In RA-treated hiPSCCMs, APD is significantly shorter as compared to DMSO-treated hiPSC-CMs (*P<0.05, two-sided ttest). C. Individual plateau amplitudes, demonstrating lower values in RA-treated hiPSC-CMs in comparison with DMSO-treated hiPSC-CMs (*P<0.05, , two-sided t-test) . D. Upstroke velocity. E.
Effects of carbachol (CCh) on maximal diastolic potential (MDP) in DMSO-and RA-treated hiPSCCMs. While no effect on MDP is found in DMSO-treated hiPSC-CMs, RA-treated hiSPC-CMs display a significant hyperpolarization upon CCh application (*P<0.05, paired t-test). B-E. DMSO, n=7; RA, n=17 hiPSC-CMs.
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